Episode

PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration

Podcast
Psychedelics Today
Published
Nov 11, 2025
Duration seconds
4921
Processing state
not_requested
Canonical source
https://psychedelicstoday.libsyn.com/pt-637-genesee-herzberg-ketamine-truths-mdma-hopes-and-the-work-of-integration
Audio
https://traffic.libsyn.com/secure/psychedelicstoday/PT_637_-_Genesee_Herzberg.mp3?dest-id=381511
JSON
/v1/public/podcasts/psychedelics-today-777076/episodes/pt-637-genesee-herzberg-ketamine-truths-mdma-hopes-and-the-work-of-integration
Markdown
/podcast/psychedelics-today-777076/pt-637-genesee-herzberg-ketamine-truths-mdma-hopes-and-the-work-of-integration.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/psychedelics-today-777076/episodes/pt-637-genesee-herzberg-ketamine-truths-mdma-hopes-and-the-work-of-integration/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/psychedelics-today-777076/pt-637-genesee-herzberg-ketamine-truths-mdma-hopes-and-the-work-of-integration.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused on ketamine-assisted therapy while preparing for MDMA's eventual approval. She also co-founded a sliding-scale KAP nonprofit (now Alchemy Community Therapy Center), co-edited Integral Psychedelic Therapy , and is helping to launch the International Alliance of MDMA Practitioners. In this episode From counterculture to mainstream: What's been gained—and lost—as psychedelics scaled. Accessibility vs. corporatization: Why cutting corners (prep/integration, therapeutic time) undermines outcomes and safety. "Myth of the magic pill": Psychedelics can catalyze change, but healing is an ongoing process anchored by integration. What good care looks like: Preparation → medicine sessions → robust integration, individualized cadence, and adding bodywork and functional medicine to address gut-brain links, mineral status, sleep, and somatic tension. Ketamine realities: Differences between psycholytic (talk-forward) and psychedelic (eyes-closed, inner-directed) dosing; why some need multiple sessions to build relationship with the medicine; risks of mail-order models (high dosing, poor screening/support), daily prescribing, addiction potential, cystitis, and safety concerns. Sitting, not guiding: T…